Letter to the Editor regarding "Assessment of drug-induced increases in blood pressure during drug development: Report from the Cardiac Safety Research Consortium"

被引：0
|
作者：
Blankfield, Robert P. [1 ]
机构：
[1] Case Western Reserve Univ, Sch Med, Berea, OH USA
来源：
AMERICAN HEART JOURNAL | 2013年 / 166卷 / 03期
关键词：
D O I：
10.1016/j.ahj.2013.06.008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E9 / E9
页数：1
相关论文
共 47 条
  • [1] Response to Letter to the Editor by Blankfield regarding "Assessment of drug-induced increases in blood pressure during drug development: Report from the Cardiac Safety Research Consortium"
    White, William B.
    Sager, Philip T.
    AMERICAN HEART JOURNAL, 2013, 166 (03) : E11 - E11
  • [2] Assessment of drug-induced increases in blood pressure during drug development: Report from the Cardiac Safety Research Consortium
    Sager, Philip
    Heilbraun, Jeffrey
    Turner, J. Rick
    Gintant, Gary
    Geiger, Mary J.
    Kowey, Peter R.
    Mansoor, George A.
    Mendzelevski, Boaz
    Michelson, Eric L.
    Stockbridge, Norman
    Weber, Michael A.
    White, William B.
    AMERICAN HEART JOURNAL, 2013, 165 (04) : 477 - 488
  • [3] Long-term electrocardiographic safety monitoring in clinical drug development: A report from the Cardiac Safety Research Consortium
    Piccini, Jonathan P.
    Clark, Richard L.
    Kowey, Peter R.
    Mittal, Suneet
    Dunnmon, Preston
    Stockbridge, Norman
    Reiffel, James A.
    Turakhia, Mintu P.
    Ziegler, Paul D.
    Kleiman, Robert B.
    Ismat, Fraz
    Sager, Philip
    AMERICAN HEART JOURNAL, 2017, 187 : 156 - 169
  • [4] AUGMENTATION OF DRUG-INDUCED BLOOD-PRESSURE INCREASES IN RATS BY AMOBARBITAL
    BUNAG, R
    MULLENIX, P
    BRITISH JOURNAL OF PHARMACOLOGY, 1972, 46 (03) : 511 - &
  • [5] Drug-induced cardiac toxicity: Emphasizing the role of electrocardiography in clinical research and drug development
    Gussak, I
    Litwin, J
    Kleiman, R
    Grisanti, S
    Morganroth, J
    JOURNAL OF ELECTROCARDIOLOGY, 2004, 37 (01) : 19 - 24
  • [6] An Assessment of Drug-Induced Changes in Cardiac Inotropy and Lusitropy Parameters in Dogs: Results from a HESI-sponsored Consortium
    Pugsley, Michael K.
    Guth, Brian D.
    Chiang, Alan Y.
    Doyle, Jennifer M.
    Engwall, Michael
    Guillon, Jean-Michel
    Hoffmann, Peter K.
    Koerner, John
    Mittelstadt, Scott
    Pierson, Jennifer Beck
    Rossman, Eric
    Parish, Stanley T.
    Sarazan, R. Dustan
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2017, 88 : 229 - 229
  • [7] Detecting drug-induced prolongation of the QRS complex: New insights for cardiac safety assessment
    Cros, C.
    Skinner, M.
    Moors, J.
    Lainee, P.
    Valentin, J. P.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2012, 265 (02) : 200 - 208
  • [8] MICROVASCULAR CHANGES DURING A DRUG-INDUCED RAPID DECREASE OF BLOOD-PRESSURE
    VACEK, L
    BRAVENY, P
    MACHOVA, L
    PHYSIOLOGIA BOHEMOSLOVACA, 1977, 26 (05): : 477 - 477
  • [9] From cancer therapy to cardiac safety: the role of proteostasis in drug-induced cardiotoxicity
    Qian, Xingyu
    Yao, Mengdong
    Xu, Jingyu
    Dong, Nianguo
    Chen, Si
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [10] Drug-induced QT interval shortening: an emerging component in integrated assessment of cardiac safety of drugs
    Shah, Rashmi R.
    Bjerregaard, Preben
    Gussak, Ihor
    JOURNAL OF ELECTROCARDIOLOGY, 2010, 43 (05) : 386 - 389
12345